Who Supplies Busulfan? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Busulfan exports, with 33+ registered manufacturers shipping to buyers across 44+ countries — yet a handful of companies dominate the shipments. EMCURE PHARMACEUTICALS LIMITED holds the largest share at 21.4% (export value: $1.1M). Close behind, INTAS PHARMACEUTICALS LIMITED (11.5%, $565.2K). FRESENIUS KABI ONCOLOGY LIMITED (9.9%, $488.1K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Busulfan? Top Manufacturers & Their Buyers
Flow of Busulfan from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Busulfan Supplier Network — Key Market Intelligence
The Busulfan export market from India is led by EMCURE PHARMACEUTICALS LIMITED, which alone commands a 21.4% share, shipping $1.1M worth of product across 109 shipments. The second-largest exporter, INTAS PHARMACEUTICALS LIMITED, contributes $565.2K (11.5%) to the overall market. Combined, the top two suppliers alone account for 32.9% of all Busulfan exports, indicating a relatively concentrated supply base.
Across all 33 tracked manufacturers, the total Busulfan export value stands at $4.9M from 369 shipments. The market average shipment value is $13.4K. The single largest buyer relationship in terms of trade value is TILLOMED LABORATORIES LIMITED, receiving $404.7K worth of product.
The combined buyer network spans 21 named purchasing companies, including TILLOMED LABORATORIES LIMITED, TILLOMED MALTA LTD, TILLOMED MALTA LIMITED, MYLAN INSTITUTIONAL INC GSO, ACCORD FARMACEUTICA LTDA and 16 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1EMCURE PHARMACEUTICALS LIMITED
EMCURE PHARMACEUTICALS LIMITED is the first-largest Busulfan exporter from India, with a market share of 21.4% and a total export value of $1.1M across 109 shipments. Their average shipment value of $9.7K is below the market average of $13.4K, reflecting a high-volume, competitive pricing strategy.
EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TILLOMED LABORATORIES LIMITED — $404.7K across 42 shipments (38.4% of this supplier's total exports)
• TILLOMED LABORATORIES LIMITED — $302.2K across 31 shipments (28.6% of this supplier's total exports)
• TILLOMED MALTA LTD — $235.8K across 24 shipments (22.3% of this supplier's total exports)
• TILLOMED MALTA LIMITED — $61.8K across 6 shipments (5.9% of this supplier's total exports)
• TILLOMED LABORATORIES LIMITED — $50.6K across 5 shipments (4.8% of this supplier's total exports)
Key Insight: EMCURE PHARMACEUTICALS LIMITED operates with high shipment frequency (109 shipments) at a per-shipment value of $9.7K, indicating a broad distribution network with many smaller, regular orders.
2INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the second-largest Busulfan exporter from India, with a market share of 11.5% and a total export value of $565.2K across 92 shipments. Their average shipment value of $6.1K is below the market average of $13.4K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MYLAN INSTITUTIONAL INC GSO — $156.5K across 25 shipments (27.7% of this supplier's total exports)
• ACCORD FARMACEUTICA LTDA — $155.2K across 25 shipments (27.5% of this supplier's total exports)
• TO THE ORDER — $93.4K across 15 shipments (16.5% of this supplier's total exports)
• EVERSANA LIFE SCIENCES SERVICES,LL — $80.4K across 13 shipments (14.2% of this supplier's total exports)
• EVERSANA LIFE SCIENCES SERVICES,LL — $79.7K across 13 shipments (14.1% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (92 shipments) at a per-shipment value of $6.1K, indicating a broad distribution network with many smaller, regular orders.
3FRESENIUS KABI ONCOLOGY LIMITED
FRESENIUS KABI ONCOLOGY LIMITED is the third-largest Busulfan exporter from India, with a market share of 9.9% and a total export value of $488.1K across 77 shipments. Their average shipment value of $6.3K is below the market average of $13.4K, reflecting a high-volume, competitive pricing strategy.
FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. FRESENIUS KABI DEUTSCHLAND GMBH is the dominant customer, accounting for 65.2% of this supplier's tracked business. Top customers include:
• FRESENIUS KABI DEUTSCHLAND GMBH — $318.3K across 50 shipments (65.2% of this supplier's total exports)
• RINQUE PHARMA S A — $54.1K across 9 shipments (11.1% of this supplier's total exports)
• FRESENIUS KABI SOUTH — $52.4K across 8 shipments (10.7% of this supplier's total exports)
• FRESENIUS KABI DEUTSCHLAND GMBH — $36.8K across 6 shipments (7.5% of this supplier's total exports)
• THE EGYPTIAN PHARMAC — $26.5K across 4 shipments (5.4% of this supplier's total exports)
Key Insight: FRESENIUS KABI ONCOLOGY LIMITED operates with high shipment frequency (77 shipments) at a per-shipment value of $6.3K, indicating a broad distribution network with many smaller, regular orders.
4INTAS PHARMACEUTICALS LTD
INTAS PHARMACEUTICALS LTD is the fourth-largest Busulfan exporter from India, with a market share of 6.6% and a total export value of $324.7K across 16 shipments. Their average shipment value of $20.3K is above the market average of $13.4K, suggesting premium or bulk contract pricing.
INTAS PHARMACEUTICALS LTD serves 5 named buyers in our database. ACCORD HEALTHCARE POLSKA SP Z O O is the dominant customer, accounting for 77.1% of this supplier's tracked business. Top customers include:
• ACCORD HEALTHCARE POLSKA SP Z O O — $250.3K across 12 shipments (77.1% of this supplier's total exports)
• ACCORD HEALTHCARE S — $30.2K across 1 shipments (9.3% of this supplier's total exports)
• ACCORD UK — $28.1K across 1 shipments (8.7% of this supplier's total exports)
• BROCACEF NL HUB BROC — $14.1K across 1 shipments (4.3% of this supplier's total exports)
• PHARMADOX HEALTHCARE — $2.0K across 0 shipments (0.6% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LTD's per-shipment value of $20.3K is 52% above the market average of $13.4K, consistent with large-order contracts or value-added formulations.
5SHILPA MEDICARE LIMITED
SHILPA MEDICARE LIMITED is the fifth-largest Busulfan exporter from India, with a market share of 3.1% and a total export value of $150.5K across 5 shipments. Their average shipment value of $30.1K is above the market average of $13.4K, suggesting premium or bulk contract pricing.
SHILPA MEDICARE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• XXPHAXXA SXX S — $61.0K across 2 shipments (40.6% of this supplier's total exports)
• XX HUXXN BXXSCIXXCE — $45.9K across 2 shipments (30.5% of this supplier's total exports)
• XX HEXXTHCXXE PXX LX — $32.5K across 1 shipments (21.6% of this supplier's total exports)
• XXIMEXXSDNXXHD — $11.1K across 0 shipments (7.4% of this supplier's total exports)
• XXHC XXC — $10 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: SHILPA MEDICARE LIMITED's per-shipment value of $30.1K is 125% above the market average of $13.4K, consistent with large-order contracts or value-added formulations.
6SP ACCURE LABS PRIVATE LIMITED
SP ACCURE LABS PRIVATE LIMITED is the fifth-largest Busulfan exporter from India, with a market share of 1.4% and a total export value of $67.2K across 4 shipments. Their average shipment value of $16.8K is above the market average of $13.4K, suggesting premium or bulk contract pricing.
SP ACCURE LABS PRIVATE LIMITED serves 1 named buyer in our database. CJSC PHARMGUIDE is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• CJSC PHARMGUIDE — $67.2K across 4 shipments (100.0% of this supplier's total exports)
Key Insight: SP ACCURE LABS PRIVATE LIMITED's per-shipment value of $16.8K is 26% above the market average of $13.4K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Busulfan Flows
Once Busulfan leaves the manufacturing plants of companies like EMCURE PHARMACEUTICALS LIMITED and INTAS PHARMACEUTICALS LIMITED, it travels to 5 destination markets with a combined import value of $4.9M. United Kingdom absorbs the largest share at 25.9% ($1.3M), followed by Peru (15.4%) and United States (11.1%).
In United Kingdom — the top destination — named importers include TILLOMED LABORATORIES LTD, TILLOMED LABORATORIES LIMITED, ACCORD UK. In Peru, key buyers are ACCORD HEALTHCARE S.A.C..
This geographic spread reflects Busulfan's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Busulfan Go? Top Importing Countries & Their Buyers
Trade flow of Busulfan exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United Kingdom
United Kingdom ranks as the first-largest destination for Busulfan imports from India, with a total trade value of $1.3M across 54 shipments — representing a 25.9% share of all Busulfan exports. The average shipment value of $23.7K is above the global average of $13.4K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Busulfan importers in United Kingdom: TILLOMED LABORATORIES LTD is the largest buyer, accounting for 48.5% ($619.7K) of this market's total imports.
• TILLOMED LABORATORIES LTD — $619.7K (48.5% of United Kingdom's total)
• TILLOMED LABORATORIES LIMITED — $404.7K (31.7% of United Kingdom's total)
• ACCORD UK — $111.6K (8.7% of United Kingdom's total)
Key Insight: United Kingdom's per-shipment average of $23.7K (77% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Busulfan imports from India.
2Peru
Peru ranks as the second-largest destination for Busulfan imports from India, with a total trade value of $756.7K across 2 shipments — representing a 15.4% share of all Busulfan exports. The average shipment value of $378.3K is above the global average of $13.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Busulfan importers in Peru: ACCORD HEALTHCARE S.A.C. is the largest buyer, accounting for 94.7% ($716.8K) of this market's total imports.
• ACCORD HEALTHCARE S.A.C. — $716.8K (94.7% of Peru's total)
Key Insight: Peru's per-shipment average of $378.3K (2733% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Peru is a key market for Busulfan imports from India.
3United States
United States ranks as the third-largest destination for Busulfan imports from India, with a total trade value of $548.0K across 10 shipments — representing a 11.1% share of all Busulfan exports. The average shipment value of $54.8K is above the global average of $13.4K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Busulfan importers in United States: EVERSANA LIFE SCIENCES SERVICES,LLC is the largest buyer, accounting for 32.8% ($179.8K) of this market's total imports.
• EVERSANA LIFE SCIENCES SERVICES,LLC — $179.8K (32.8% of United States's total)
• MYLAN INSTITUTIONAL INC GSO — $156.5K (28.6% of United States's total)
• EVERSANA LIFE SCIENCES SERVICES,LL — $80.4K (14.7% of United States's total)
Key Insight: United States's per-shipment average of $54.8K (310% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Busulfan imports from India.
4Germany
Germany ranks as the fourth-largest destination for Busulfan imports from India, with a total trade value of $463.2K across 60 shipments — representing a 9.4% share of all Busulfan exports. The average shipment value of $7.7K is below the global average of $13.4K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.
Named Busulfan importers in Germany: FRESENIUS KABI DEUTSCHLAND GMBH is the largest buyer, accounting for 92.1% ($426.4K) of this market's total imports.
• FRESENIUS KABI DEUTSCHLAND GMBH — $426.4K (92.1% of Germany's total)
Key Insight: Germany receives frequent, smaller shipments of Busulfan — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Germany is a key market for Busulfan imports from India.
5Malta
Malta ranks as the fifth-largest destination for Busulfan imports from India, with a total trade value of $341.9K across 22 shipments — representing a 6.9% share of all Busulfan exports. The average shipment value of $15.5K is above the global average of $13.4K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Busulfan importers in Malta: TILLOMED MALTA LTD is the largest buyer, accounting for 69.0% ($235.8K) of this market's total imports.
• TILLOMED MALTA LTD — $235.8K (69.0% of Malta's total)
• TILLOMED MALTA LIMITED — $61.8K (18.1% of Malta's total)
Key Insight: Malta's per-shipment average of $15.5K (16% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Malta is a key market for Busulfan imports from India.
People Also Ask — Busulfan Supplier & Trade Network
Who are the top suppliers of Busulfan from India?+
Which companies buy Busulfan from Indian manufacturers?+
Where does Busulfan exported from India go?+
What is the market share of the top Busulfan supplier from India?+
What is the average shipment value for Busulfan exports from India?+
Is Busulfan manufactured in India and exported globally?+
Which country imports the most Busulfan from India?+
Who are the buyers of Busulfan in Peru?+
How concentrated is the Busulfan supplier market in India?+
How do I find verified buyers for Busulfan in specific countries?+
Busulfan Trade Network — Key Takeaways
- 1EMCURE PHARMACEUTICALS LIMITED is India's dominant Busulfan exporter with a 21.4% market share and $1.1M in total exports — making it the single most important sourcing entity in this market.
- 2The top 33 suppliers collectively account for 53.8% of all tracked Busulfan exports, with a combined trade value of $4.9M.
- 3United Kingdom is the largest destination market, absorbing 25.9% of India's Busulfan exports ($1.3M). Peru (15.4%) and United States (11.1%) follow.
- 4With 369 total shipments averaging $13.4K each, the Busulfan export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include TILLOMED LABORATORIES LIMITED, TILLOMED LABORATORIES LIMITED, MYLAN INSTITUTIONAL INC GSO, ACCORD FARMACEUTICA LTDA — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 44 countries
Network value: $4.9M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Busulfan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Busulfan.
- 2.Flow Mapping: 33 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 369 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 44 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
369 Verified Shipments
33 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists